Top searches

PL

Resources

B2RLaw advises Proteon Pharmaceuticals on a strategic partnership with Skretting

01/02/2021

B2RLaw has advised Proteon Pharmaceuticals on a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry.

The companies will collaborate on developing products using bacteriophage technology to support aquaculture farmers as part of a holistic health strategy. The companies will work in a parallel R&D pipeline on the project.

The Partnership allows Proteon to grow its product portfolio in aquaculture and expand its presence worldwide. Both Proteon Pharmaceuticals and Skretting predict that the technology will become a valuable component of integrated management strategies on-farm with both feed and water applications under investigation.

Proteon Pharmaceuticals is a Polish originating biotech company with a vision to develop natural feed additives that help remove antibiotics from the food chain and improve animal and human health. The Company uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

Norwegian company, Skretting is the world’s largest producer of feeds for farmed fish. The Company has operations on five continents and produces 2.5 million tonnes of feed annually, for more than sixty species of fish. Skretting has 3,500 employees worldwide. Skretting has an R&D unit known as Skretting Aquaculture Research Centre (ARC) with the main objective to provide research and technical support regarding fish and shrimp feed. It has 140 employees representing 25 nationalities.

B2RLaw’s team advising Proteon Pharmaceuticals was led by Partner George Havaris and included Counsels Paulina Wyrostek and Malwina Niczke – Chmura.

George Havaris advises, “Proteon Pharmaceuticals is a Polish company that is well on the path to being a global leader in its field of operation. Animal health is a little-known industry in the wider public eye. However, animal health is fundamental to the health and well-being of humans. We congratulate Proteon and Skretting on this exciting Partnership and we look forward to continuing our support to Proteon on its growth path”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

16/05/2023

Andrzej Zając appointed as a Head of the Energy & Real Estate Practice in B2RLaw

Andrzej is an attorney-at-law with almost 20 years of professional experience. Andrzej is a lawyer focusing his practice on complex […]

MORE
17/04/2023

B2RLaw announces lawyer promotions

We are very pleased to announce five lawyer promotions in B2RLaw in its 2022/2023 promotion round. The lawyers that have […]

MORE
28/04/2023

B2RLaw at the IFG Asset Recovery Conference: 27-28 April in Toronto

Meet our B2RLaw team: Edyta Zalewska (Advocate, Partner) and Roman Iwański (Advocate, Partner) at the Annual Spring Members’ Meeting! We are […]

MORE
13/04/2023

B2RLaw recommended in the Legal 500 EMEA ranking 2023

We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 6 […]

MORE
04/04/2023

B2RLaw one of only 6 law firms in Poland recognized by Legal 500 in its Green Guide EMEA 2023

We are pleased to announce that B2RLaw has been inducted into the 2023 second edition of Legal 500’s Europe, Middle […]

MORE
28/03/2023

B2RLaw advises Bentley Systems’ Cohesive Group on its acquisition of Vetasi

B2RLaw has advised Bentley Systems, Incorporated, the infrastructure engineering software company, and its Cohesive Group digital integrator business, on the […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close